https://imedic.health/en/health/news/tzield-approval-preserve-insulin-children-new-type-1-diabetes iMedic en 2026-08-03 Tzield Approval Expands Treatment for Children With New Type 1 Diabetes https://imedic.health/en/health/news/rituximab-biosimilar-fda-approval-b-cell-treatment-access iMedic en 2026-08-03 FDA-Approved Rituximab Biosimilar Adds a New B-Cell Therapy Option https://imedic.health/en/health/news/initial-hiv-therapy-weight-gain-doravirine-regimen-choices iMedic en 2026-08-03 Initial HIV Therapy and Weight Gain: How Doravirine May Shape Regimen Choices https://imedic.health/en/health/news/ziltivekimab-heart-disease-trial-inflammation-results iMedic en 2026-08-03 Ziltivekimab Heart Trial Tests the Limits of Targeting Inflammation https://imedic.health/en/health/news/pan-ras-drugs-pancreatic-cancer-kras-treatment iMedic en 2026-08-03 Pan-RAS Drugs Could Expand Targeted Treatment for Pancreatic Cancer https://imedic.health/en/health/news/fda-staffing-strain-drug-review-safety-oversight iMedic en 2026-08-03 FDA Staffing Strain Raises Risks for Drug Reviews and Safety Oversight https://imedic.health/en/health/news/pediatric-antidepressant-anxiety-medication-florida-guidance iMedic en 2026-08-03 Pediatric Antidepressants and Anxiety Medicines: What New Florida Guidance Means https://imedic.health/en/health/news/inflammation-biomarkers-heart-drug-trials iMedic en 2026-08-04 Why Lowering Inflammation Markers May Not Prevent Heart Attacks https://imedic.health/en/health/news/kras-mutation-testing-pancreatic-cancer-targeted-drugs iMedic en 2026-08-04 KRAS Mutation Testing in Pancreatic Cancer: What New Targeted Drugs Could Change https://imedic.health/en/health/news/antithrombotic-treatment-migraine-patent-foramen-ovale-trial iMedic en 2026-08-04 Blood-Thinning Treatment for Migraine With Patent Foramen Ovale: What the Trial Means